Breaking News Instant updates and real-time market news.

CTRP

Ctrip.com

$40.99

-0.88 (-2.10%)

05:48
11/25/16
11/25
05:48
11/25/16
05:48

JPMorgan turning more positive on Ctrip.com outlook

JPMorgan analyst Alex Yao says he's turning more positive on Ctrip.com's profit outlook following the company's Q3 results. The company's operating efficiency is improving while Qunar is turning profitable, Yao tells investors in a research note. The analyst views the Skyscanner acquisition as "solid progress" toward expanding into the addressable market for the outbound travel business. He maintains an Overweight rating on Ctrip.com with a $55 price target. The Chinese travel service provider is up $3.51 to $44.50 in pre-market trading.

CTRP Ctrip.com
$40.99

-0.88 (-2.10%)

10/06/16
10/06/16
NO CHANGE

Ctrip.com Q3 net revenue forecast trending above guidance, says M Science
10/25/16
GSCO
10/25/16
NO CHANGE
GSCO
Conviction Buy
Alibaba price target raised to $130 from $120 at Goldman
Goldman Sachs analyst Piyush Mubayi continues to think the outlook for organic growth rates in Alibaba's (BABA) China retail business remains robust and that the margin outlook for its core businesses is also intact. The analyst raised his price target on Alibaba shares to $130 from $120 and reiterates a Conviction List Buy rating on the stock, which remains his top pick in its sector. In the Chinese Internet space, the analyst also has Buy ratings on Tencent (TCEHY), Baidu (BIDU), JD.com (JD), Ctrip.com (CTRP), NetEase (NTES) and Vipshop (VIPS).
11/14/16
OPCO
11/14/16
NO CHANGE
Target $55
OPCO
Outperform
Ctrip.com pullback creates attractive buying opportunity, says Oppenheimer
Oppenheimer analyst Jed Kelly believes the recent pullback in Ctrip.com's shares creates an attractive buying opportunity. The analyst expects "solid" Q3 results, with Q4 guidance likely bracketing Street estimates. He reiterates an Outperform rating and $55 price target on the shares.
11/25/16
HSBC
11/25/16
UPGRADE
HSBC
Buy
Ctrip.com upgraded to Buy from Hold at HSBC (yesterday)

TODAY'S FREE FLY STORIES

IOVA

Iovance Biotherapeutics

$10.70

1.075 (11.17%)

09:12
01/22/18
01/22
09:12
01/22/18
09:12
Recommendations
Iovance Biotherapeutics analyst commentary  »

Iovance Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

09:11
01/22/18
01/22
09:11
01/22/18
09:11
Hot Stocks
Halliburton says International business started to recover in 2H17 »

Comments from Q4 earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

09:10
01/22/18
01/22
09:10
01/22/18
09:10
General news
Treasury Option Action: doubly bullish positioning »

Treasury Option Action:…

GRA

W.R. Grace

$73.71

0.92 (1.26%)

09:09
01/22/18
01/22
09:09
01/22/18
09:09
Hot Stocks
W.R. Grace licenses UNIPOL PP process technology to Poland's Grupa Azoty »

W. R. Grace has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

  • 02

    Mar

PRI

Primerica

$104.50

1.3 (1.26%)

09:09
01/22/18
01/22
09:09
01/22/18
09:09
Recommendations
Primerica analyst commentary  »

Primerica price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

ARCT

Arcturus Therapeutics

$9.15

-0.15 (-1.61%)

09:08
01/22/18
01/22
09:08
01/22/18
09:08
Initiation
Arcturus Therapeutics initiated  »

Arcturus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTH

Meritage Homes

$52.15

0.45 (0.87%)

09:08
01/22/18
01/22
09:08
01/22/18
09:08
Upgrade
Meritage Homes rating change  »

Meritage Homes upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

INSG

Inseego

$1.66

-0.01 (-0.60%)

09:08
01/22/18
01/22
09:08
01/22/18
09:08
Hot Stocks
Inseego says board adopts NOL rights plan »

Inseego Corp. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WYNN

Wynn Resorts

$179.64

4.16 (2.37%)

09:06
01/22/18
01/22
09:06
01/22/18
09:06
Hot Stocks
Breaking Hot Stocks news story on Wynn Resorts »

Wynn Resorts reports Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

XRX

Xerox

$31.80

0.43 (1.37%)

09:06
01/22/18
01/22
09:06
01/22/18
09:06
Hot Stocks
Icahn, Deason call on Xerox to explore strategic alternatives, replace CEO »

Carl Icahn and Darwin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WYNN

Wynn Resorts

$179.64

4.16 (2.37%)

09:05
01/22/18
01/22
09:05
01/22/18
09:05
Hot Stocks
Breaking Hot Stocks news story on Wynn Resorts »

Wynn Resorts reports Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

WYNN

Wynn Resorts

$179.64

4.16 (2.37%)

09:05
01/22/18
01/22
09:05
01/22/18
09:05
Earnings
Wynn Resorts reports Q4 adjusted EPS $1.40, consensus $1.38 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

FFBC

First Financial Bancorp

09:04
01/22/18
01/22
09:04
01/22/18
09:04
Upgrade
First Financial Bancorp rating change  »

First Financial Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DVAX

Dynavax

, GSK

GlaxoSmithKline

$38.20

0.03 (0.08%)

09:04
01/22/18
01/22
09:04
01/22/18
09:04
Recommendations
Dynavax, GlaxoSmithKline analyst commentary  »

Dynavax has sold off 30%…

DVAX

Dynavax

GSK

GlaxoSmithKline

$38.20

0.03 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

  • 26

    Feb

  • 25

    Mar

  • 23

    Apr

EGP

EastGroup Properties

$84.88

1.43 (1.71%)

09:04
01/22/18
01/22
09:04
01/22/18
09:04
Upgrade
EastGroup Properties rating change  »

EastGroup Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

ENZ

Enzo Biochem

$7.96

0.17 (2.18%)

09:04
01/22/18
01/22
09:04
01/22/18
09:04
Hot Stocks
Enzo Biochem announces validation of cervical cancer biomarker detection test »

Enzo Biochem announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRS

Harris

$145.89

0.15 (0.10%)

09:03
01/22/18
01/22
09:03
01/22/18
09:03
Hot Stocks
Harris selected by U.S. Air Force for F-16 EW system support program »

The U.S. Air Force has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 21

    Feb

LGND

Ligand

$155.81

5.25 (3.49%)

09:01
01/22/18
01/22
09:01
01/22/18
09:01
Hot Stocks
Ligand, Ferring Pharmaceuticals enter into OmniAb platform license agreement »

Ligand Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTR

Frontier Communications

$7.77

0.56 (7.77%)

09:01
01/22/18
01/22
09:01
01/22/18
09:01
Hot Stocks
Frontier Communications launches Total360 continuity service nationwide »

Frontier Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

BAESY

BAE Systems

$33.30

0.18 (0.54%)

09:01
01/22/18
01/22
09:01
01/22/18
09:01
Hot Stocks
BAE Systems to provide U.S. Navy with modernized Mk 45 guns in $46.8M contract »

The U.S. Navy has awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WRI

Weingarten Realty

$30.76

0.26 (0.85%)

09:00
01/22/18
01/22
09:00
01/22/18
09:00
Upgrade
Weingarten Realty rating change  »

Weingarten Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

IDRA

Idera Pharmaceuticals

$2.55

0.145 (6.03%)

09:00
01/22/18
01/22
09:00
01/22/18
09:00
Hot Stocks
Breaking Hot Stocks news story on Idera Pharmaceuticals »

Idera Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCRX

BioCryst

$5.59

-0.09 (-1.58%)

09:00
01/22/18
01/22
09:00
01/22/18
09:00
Hot Stocks
Breaking Hot Stocks news story on BioCryst 

BioCryst trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEN

Lennar

$71.82

1.28 (1.81%)

08:58
01/22/18
01/22
08:58
01/22/18
08:58
Upgrade
Lennar rating change  »

Lennar upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BG

Bunge

$77.56

7.92 (11.37%)

, ADM

Archer Daniels

$40.96

0.48 (1.19%)

08:57
01/22/18
01/22
08:57
01/22/18
08:57
Recommendations
Bunge, Archer Daniels analyst commentary  »

Citi sees $85-$100 per…

BG

Bunge

$77.56

7.92 (11.37%)

ADM

Archer Daniels

$40.96

0.48 (1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 14

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.